Keyphrases
Patient-derived Xenograft
100%
Pancreaticobiliary Cancer
100%
Postoperative Survival
100%
Postoperative Recurrence
100%
Growth Correlation
100%
Engraftment
66%
Overall Survival
33%
Xenograft
33%
Patient-derived Tumor Xenograft
33%
Pancreaticobiliary
33%
Clinical Recurrence
33%
Cancer Patients
16%
Patient Treatment
16%
Malignancy
16%
Tumor Growth
16%
Recurrence Rate
16%
Surgical Specimen
16%
Poor Prognosis
16%
Pathologist
16%
Patient Tumor
16%
Tumor Subtype
16%
Tumor Tissue
16%
Engraftment Rate
16%
Immunodeficient Mice
16%
Survival Data
16%
Cancer Model
16%
Resection
16%
Carcinoma
16%
Medical Surveillance
16%
Diverse Groups
16%
Cancer Recurrence
16%
Recapitulation
16%
Preclinical Research
16%
Surgical Patients
16%
Surveillance Strategy
16%
Animal Care
16%
Treatment Plan
16%
Recurrence-free Survival
16%
Hepatobiliary
16%
Animal Use
16%
Oncological Outcomes
16%
Biliary Tract
16%
Tumor of Origin
16%
Medicine and Dentistry
Malignant Neoplasm
100%
Recurrent Disease
100%
Xenograft
100%
Engraftment
62%
Neoplasm
50%
Cancer
37%
Overall Survival
25%
Tumor Xenograft
25%
Tumor Progression
12%
Pathologist
12%
Cancer Model
12%
Carcinoma
12%
Cancer Recurrence
12%
Hepatobiliary System
12%
Recurrence Free Survival
12%